Unusual and memorable
Unusual and memorable
| The first 100% of the full text of this article appears below. |
This 58 year old woman has a history of seropositive rheumatoid arthritis for 25 years. Her disease was controlled with 50 mg sodium aurothiomalate every three weeks for the past 21 years. Recently she had noticed a change in her skin colour.
| Figure Removed (Available Only in the Full Text) |
On examination she had slate grey pigmentation over her face, neck, and hands, most marked in the periorbital region. There was no history of amiodarone ingestion. There was no history of respiratory disease and arterial blood gases were normal. She did not have haemochromatosis.
Chrysiasis secondary to longstanding sodium aurothiomalate treatment was first described in 1928.1 It is a photodependent pigmentation resulting from aurosomes gathering in light exposed regions.
The phenomenon is dose dependent, the severe form being reported after a cumulative dose of 263 mg/kg of sodium aurothiomalate.2 This woman had a cumulative dose of 787 mg/kg. It is a benign condition but has a high potential for misdiagnosis if unrecognised.
Contributors: SINEAD M LANGAN, CLAIRE HARRISON, GARY D WRIGHT. Department of Rheumatology, Royal Victoria Hospital, Belfast.
References
| 1. | Hansborg H. Chrysiasis-ablagerung van gold in vivo. Acta Tuberc Scand 1928;4:124-132. |
| 2. |
Smith RW,
Cawley MID. Chrysiasis.
Br J Rheumatol
1997;36:3-5 |
© 1999 by Annals of the Rheumatic Diseases
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
